Cynthia Egan - BlackRock Science Independent Trustee
| BST Etf | USD 36.68 0.23 0.63% |
| Age | 66 |
| Tenure | 8 years |
| Phone | 212 810 5300 |
| Web | https://www.blackrock.com/investing/products/270141/blackrock-science-and-technology-trust-fund |
Similar Fund Executives
| Showing other executives | One Year Return | ||
| Kathleen Anderson | BlackRock Utility Infrastructur | N/A | |
| Stayce Harris | BlackRock Health Sciences | 62 | |
| Janey Ahn | Blackrock Innovation Growth | 46 | |
| Karen Robards | Blackrock Innovation Growth | 71 | |
| George Batejan | Columbia Seligman Premium | 67 | |
| CFA CFA | BlackRock Utility Infrastructur | N/A | |
| Xiang Liu | BlackRock Health Sciences | N/A | |
| Robin Batchelor | BlackRock Utility Infrastructur | N/A | |
| Charles Park | Blackrock Innovation Growth | 54 | |
| Catherine Lynch | BlackRock Health Sciences | 60 | |
| W Kester | BlackRock Health Sciences | 70 | |
| Antonio III | BlackRock Utility Infrastructur | 56 | |
| W Kester | Blackrock Innovation Growth | 70 | |
| Jeffrey Lee | BlackRock Health Sciences | N/A | |
| Keith Quinton | Eaton Vance Enhanced | 63 | |
| Christopher Accettella | BlackRock Utility Infrastructur | N/A | |
| Jonathan Diorio | BlackRock Health Sciences | 41 | |
| Robert Fairbairn | Blackrock Innovation Growth | 56 | |
| R Hubbard | Blackrock Innovation Growth | 63 | |
| Jonathan Diorio | Blackrock Innovation Growth | 41 | |
| Marcus Smith | Eaton Vance Enhanced | 54 | |
BlackRock Science Tech Money Managers
| Henry Gabbay, Independent Trustee | ||
| Karen Robards, Independent Co-Chairman of the Board of Trustees | ||
| Richard Cavanagh, Independent Co-Chairman of the Board of Trustees | ||
| Charles Park, Chief Compliance Officer, Anti-Money Laundering Officer | ||
| Frank Fabozzi, Independent Trustee | ||
| J Holloman, Independent Trustee | ||
| Janey Ahn, Secretary | ||
| John Perlowski, President, Chief Executive Officer, Trustee | ||
| Michael Castellano, Independent Trustee | ||
| Cynthia Egan, Independent Trustee | ||
| Jay Fife, Treasurer | ||
| R Hubbard, Independent Trustee | ||
| Jonathan Diorio, Vice President | ||
| Robert Fairbairn, Trustee | ||
| Neal Andrews, Chief Financial Officer | ||
| Trent Walker, Chief Financial Officer | ||
| Catherine Lynch, Independent Trustee | ||
| Stayce Harris, Independent Trustee | ||
| W Kester, Independent Trustee |
BlackRock Etf Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right etf is not an easy task. Is BlackRock Science a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Shares Outstanding | 33.68 M | ||||
| Shares Owned By Insiders | 0.01 % | ||||
| Shares Owned By Institutions | 18.53 % | ||||
| Number Of Shares Shorted | 14.74 K | ||||
| Price To Earning | 5.78 X | ||||
| Short Ratio | 0.09 X | ||||
| Earnings Per Share | 5.41 X | ||||
| Number Of Employees | 17 | ||||
| Market Capitalization | 1 B | ||||
| Total Asset | 22.91 M |
Thematic Opportunities
Explore Investment Opportunities
Other Information on Investing in BlackRock Etf
BlackRock Science financial ratios help investors to determine whether BlackRock Etf is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BlackRock with respect to the benefits of owning BlackRock Science security.